π₯π BizChicken ππ₯
Companies Similar to GeneDx Holdings Corp.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Bio-Path Holdings, Inc.
DNAbilize
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused RNAi nano particle drug development company, developing products based on the DNAbilize technology. The company is advancing its lead drug candidate, prexigebersen, for the treatment of AML and myelodysplastic syndrome.
Symbol: BPTH
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. Peter H. Nielsen MBA
Sector: Healthcare
Employees: 10
Address: 4710 Bellaire Boulevard, Bellaire, TX 77401
Phone: 832 742 1357
Leadership
- Peter Nielsen, Chief Executive Officer, Chief Financial Officer
- Ana Tari Ashizawa, PhD, MBA, Senior Vice President of Research, Development & Clinical Design
- Anthony Price, MBA, Senior Vice President of Finance, Accounting & Administration
- Michael Hickey, MBA, Vice President of Clinical Operations
- Michael Roberts, Director of Manufacturing Planning & Engineering
- Chairman of the Board,
- President,
- Heath Cleaver, Director
- Paul Aubert, Director
- Douglas P. Morris, Director
- Aline Sherwood, Director
Last updated: 2024-12-31
Health Catalyst, Inc.
Data and Analytics Platform
Health Catalyst provides data and analytics technology and services to healthcare organizations, facilitating AI integration, population health management, financial transformation, quality and safety improvement, and a national data ecosystem.
Symbol: HCAT
Recent Price: $7.01
Industry: Medical - Healthcare Information Services
CEO: Mr. Daniel D. Burton
Sector: Healthcare
Employees: 1300
Address: 10897 South River Front Parkway, South Jordan, UT 84095
Phone: 801 708 6800
Last updated: 2024-12-31
GE HealthCare Technologies Inc.
Healthcare products and digital solutions
GE Health Care Technologies Inc. develops, manufactures, and markets products, services, and digital solutions for patient diagnosis, treatment, and monitoring globally. It operates through segments including Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
About | Contact | About | Sustainability | News | About | Sustainability | Foundation | About | About | About | About | About | Jobs | Careers | Careers | Jobs | Jobs | Careers | Careers | DEI | Culture | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Culture | DEI | Careers | Sustainability | Careers | Careers | Careers | Careers | Vision/Values | Careers | Jobs | About | About | About | About | About
Symbol: GEHC
Recent Price: $78.60
Industry: Medical - Healthcare Information Services
CEO: Mr. Peter J. Arduini
Sector: Healthcare
Employees: 51000
Address: 500 West Monroe Street, Chicago, IL 60661
Phone: 617 443 3400
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
GeneDx Holdings Corp.
Centrellis health intelligence platform
Gene Dx Holdings Corp. is a patient-centered health intelligence company focused on transforming healthcare by leveraging AI and machine learning on clinical and genomic data to improve individual health outcomes.
Symbol: WGS
Recent Price: $76.58
Industry: Medical - Healthcare Information Services
CEO: Ms. Katherine A. Stueland
Sector: Healthcare
Employees: 1000
Address: North Tower, Stamford, CT 06902
Phone: 800 298 6470
Last updated: 2024-12-31
ALX Oncology Holdings Inc.
ALX148
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.
About | Contact | About | About | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Careers | Jobs
Symbol: ALXO
Recent Price: $1.66
Industry: Biotechnology
CEO: Mr. Jason W. Lettmann
Sector: Healthcare
Employees: 81
Address: 323 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 466 7125
Last updated: 2024-12-31
Cardio Diagnostics Holdings, Inc.
Epi+Gen CHD
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease, offering products like Epi+Gen CHD to assess risk and personalize care using AI and precision epigenetics.
Symbol: CDIO
Recent Price: $0.82
Industry: Biotechnology
CEO: Dr. Meeshanthini V. Dogan Ph.D.
Sector: Healthcare
Employees: 7
Address: 400 N Aberdeen St, Chicago, IL 60642
Phone: 855 226 9991
Last updated: 2024-12-31
Celcuity Inc.
CELsignia diagnostic platform
Celcuity Inc., a biotechnology company, develops targeted therapies for cancer patients in the US, including the CELsignia diagnostic platform and Gedatolisib drug candidate.
Symbol: CELC
Recent Price: $13.13
Industry: Biotechnology
CEO: Mr. Brian F. Sullivan
Sector: Healthcare
Employees: 55
Address: 16305β36th Avenue North, Minneapolis, MN 55446
Phone: 763 392 0767
Leadership
- Brian Sullivan, CEO and Co-founder
- Lance Laing, PhD, Chief Science Officer and Co-founder
- Vicky Hahne, CFO
- Igor Gorbatchevsky, MD, Chief Medical Officer
- Eldon Mayer, Chief Commercial Officer
- Brent Eilefson, General Counsel
- Bernhard Lampert, PhD, VP of Pharmaceutical Development
- Nadene Zack, VP Clinical Operations
- Sunni Miller, VP of Regulatory Affairs
- David Bridge, VP of Quality Assurance and Process Development
- William Strickland, PharmD, VP of Medical Affairs
- Fred Kerwood, VP of Program Management
- Charlotte Moser, MD, PhD, SVP of Clinical Development
- John R. MacDonald, PhD, SVP of R&D
- Lance Laing, PhD, Chief Science Officer and Co-Founder
- Richard Buller, MD, PhD, Director
- David F. Dalvey, Director
- Leo Furcht, MD, Director
- Polly Murphy, DVM, PhD, Director
- Richard J. Nigon, Director
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Lexeo Therapeutics, Inc. Common Stock
LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004
Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.
Symbol: LXEO
Recent Price: $6.54
Industry: Biotechnology
CEO: Mr. R. Nolan Townsend
Sector: Healthcare
Employees: 69
Address: 345 Park Avenue South, New York, null 10010
Phone: 212-547-9879
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Personalis, Inc.
NeXT Platform
Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.
About | Contact | Contact | Contact | Careers | Careers | Careers | About | About | Careers | About | About | About
Symbol: PSNL
Recent Price: $5.97
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher M. Hall
Sector: Healthcare
Employees: 223
Address: 1330 OβBrien Drive, Menlo Park, CA 94025
Phone: 650 752 1300
Last updated: 2024-12-31
Quanterix Corporation
HD-X, SR-X, SP-X instruments
Quanterix Corporation develops and markets digital immunoassay platforms to advance precision health in life sciences research and diagnostics globally, offering products like the HD-X, SR-X, and SP-X instruments, assay kits, and providing contract research services across areas such as neurology, oncology, and cardiology.
About | Contact | About | About | Careers | About | About | About | About | Jobs | About | About | About | About | About
Symbol: QTRX
Recent Price: $10.90
Industry: Medical - Devices
CEO: Dr. Masoud Toloue Ph.D.
Sector: Healthcare
Employees: 441
Address: Building 1, Billerica, MA 01821
Phone: 617 301 9400
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Grid Dynamics Holdings, Inc.
Enterprise-Level Digital Transformation Services
Grid Dynamics Holdings, Inc. provides enterprise-level digital transformation services, including search, analytics, and release automation, for Fortune 1000 corporations worldwide. They offer strategy consulting, prototypes, and delivery of digital platforms.
About | About | Contact | About | Careers | Careers | Careers | Leadership | Locations | Careers | About | About | About | About | Management | About | About | About | About | About | About | About | About | About | About | About | About | About | Leadership | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: GDYN
Recent Price: $22.50
Industry: Information Technology Services
CEO: Mr. Leonard Livschitz
Sector: Technology
Employees: 4298
Address: 5000 Executive Parkway, San Ramon, CA 94583
Phone: 650 523 5000
Leadership
- Tijana, Delivery Manager
- Anderson, Software Engineer
- Alex, Principal Data Scientist
- Grid Dynamics, Company
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
Lantheus Holdings, Inc.
DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
Symbol: LNTH
Recent Price: $89.13
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Brian A. Markison
Sector: Healthcare
Employees: 834
Address: 331 Treble Cove Road, North Billerica, MA 01862
Phone: 978 671 8001
Leadership
- Brian Markison, Chief Executive Officer
- Paul Blanchfield, President
- Jeff Humphrey, MD, Chief Medical Officer
- Robert J. Marshall Jr., Chief Financial Officer
- Amanda Morgan, Chief Commercial Officer
- Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
- Jean-Claude Provost, MD, Chief Science Officer
- Jamie Spaeth, Chief People Officer
- Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
- Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
- Kim Brown, Chief Accounting Officer
- Lee Anne Howe, Chief Information Officer
- Linda Lennox, Chief of Staff & Vice President, Corporate Communications
- Joann Nestor, Senior Vice President, Legal Affairs
- Andrea Sabens, Vice President, Business Optimization
- Carol Walker, Senior Vice President, Quality
- Mary Anne Heino, Chairperson of the Board
- Minnie Baylor-Henry, Director
- GΓ©rard Ber, PhD, Director
- Julie Eastland, Director
- Samuel Leno, Director
- Heinz MΓ€usli, Director
- Julie McHugh, Director
- Gary J. Pruden, Director
- James H. Thrall, MD, Director
Last updated: 2024-12-31
MeiraGTx Holdings plc
Gene Therapy Treatments
Meira GTx Holdings plc is a clinical stage gene therapy company developing treatments for serious diseases, including ocular diseases, xerostomia, and neurodegenerative conditions. They are in various stages of clinical development for several gene therapy programs and have a research collaboration with Janssen Pharmaceuticals.
About | Leadership | About | Contact | About | About | About | News | About | About | About | Directors
Symbol: MGTX
Recent Price: $5.89
Industry: Biotechnology
CEO: Dr. Alexandria Forbes Ph.D.
Sector: Healthcare
Employees: 387
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 860 7985
Leadership
- Alexandria Forbes, Ph.D., Board Member, President and Chief Executive Officer
- Richard Giroux, Chief Operating Officer and Chief Financial Officer
- Stuart Naylor, Ph.D., Chief Development Officer
- Robert K. Zeldin, M.D., Chief Medical Officer
- Robert Wollin, JD, General Counsel and Secretary
- Alastair Leighton, Ph.D, SVP, Manufacturing and Supply Chain
- Christine Sheehy, SVP, Global Integration
- Tim Randall, SVP, Risk and Internal Controls
- Michel Michaelides, M.D., Head of Clinical Ophthalmology
- Tassos Georgiadis, Ph.D., Vice President, Preclinical Development
- Keith R. Harris, Ph.D., Chairman of the Board
- Ellen Hukkelhoven, Ph.D., Board Member
- Lord Mendoza, Independent Board Member
- Nicole Seligman, Independent Board Member
- Thomas E. Shenk, Ph.D., Independent Board Member
- Debra Yu, M.D., Independent Board Member
Last updated: 2024-12-31
Zeta Global Holdings Corp.
Zeta Marketing Platform
Zeta Global Holdings Corp. provides an omnichannel data-driven cloud platform for consumer intelligence and marketing automation, utilizing machine learning algorithms to analyze data and predict consumer intent.
Our Story | About | Leadership | Locations | Contact | About | Our Story | Contact | About | About | About | About
Symbol: ZETA
Recent Price: $18.06
Industry: Software - Application
CEO: Mr. David A. Steinberg
Sector: Technology
Employees: 1783
Address: 3 Park Avenue, New York, NY 10016
Phone: 212 967 5055
Leadership
- David A. Steinberg, Co-Founder, Chairman, CEO
- John Sculley, Co-Founder, Vice Chairman and Director
- Steven Gerber, President and Chief Operating Officer
- Christopher Greiner, Chief Financial Officer
- Steve Vine, EVP of Mergers and Acquisitions and General Counsel
- Candice Chafey, Chief People Officer
- Christian Monberg, Chief Technology Officer and Head of Product
- Neej Gore, Chief Data Officer
- Will Margiloff, Chief Growth Officer
- Kelly Kennedy, Chief Revenue Officer of CRM
- Matthew Mobley, President of Zeta CRM
- Jed Hartman, President of Activation Partnerships
- Dr. Jeffry Nimeroff, Chief Information Officer
- Narendra Amarineni, President of Zeta Actions
- Tina McCain, EVP, Client Partnerships
- Rob Lentz, EVP of Enterprise Operations
- Bharat Goyal, EVP and Head of Engineering
- Harrison Davies, President of Media Activation
- Bryan Seltzer, President, ZX
- Kurt Baumgarten, CISO and VP, Information Security
- Benjamin Hayes, SVP, Privacy & Chief Privacy Officer
- Kara Trivunovic, SVP, Strategic Solutions
- Yara Lutz, SVP, Customer Success
Last updated: 2024-12-31